日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Tucatinib plus trastuzumab for chemotherapy-refractory, HER2 + , RAS wild-type metastatic colorectal cancer (MOUNTAINEER): final analysis

图卡替尼联合曲妥珠单抗治疗化疗难治性、HER2阳性、RAS野生型转移性结直肠癌(MOUNTAINEER研究):最终分析

Strickler, John H; Cercek, Andrea; Siena, Salvatore; André, Thierry; Ng, Kimmie; Van Cutsem, Eric; Wu, Christina; Paulson, Andrew Scott; Hubbard, Joleen M; Coveler, Andrew L; Fountzilas, Christos; Kardosh, Adel; Kasi, Pashtoon Murtaza; Lenz, Heinz-Josef; Ciombor, Kristen; Elez, Elena; Bajor, David L; Cremolini, Chiara; Sanchez, Federico; Nayeri, Mina; Feng, Wentao; Bieda, Mark; Bekaii-Saab, Tanios S

Encorafenib, Cetuximab, and mFOLFOX6 in BRAF-Mutated Colorectal Cancer

恩科拉非尼、西妥昔单抗和mFOLFOX6治疗BRAF突变型结直肠癌

Elez, Elena; Yoshino, Takayuki; Shen, Lin; Lonardi, Sara; Van Cutsem, Eric; Eng, Cathy; Kim, Tae Won; Wasan, Harpreet Singh; Desai, Jayesh; Ciardiello, Fortunato; Yaeger, Rona; Maughan, Timothy S; Morris, Van K; Wu, Christina; Usari, Tiziana; Laliberte, Robert; Dychter, Samuel S; Zhang, Xiaosong; Tabernero, Josep; Kopetz, Scott

Encorafenib, cetuximab and chemotherapy in BRAF-mutant colorectal cancer: a randomized phase 3 trial

恩科拉非尼、西妥昔单抗和化疗治疗BRAF突变型结直肠癌:一项随机3期试验

Kopetz, Scott; Yoshino, Takayuki; Van Cutsem, Eric; Eng, Cathy; Kim, Tae Won; Wasan, Harpreet Singh; Desai, Jayesh; Ciardiello, Fortunato; Yaeger, Rona; Maughan, Timothy S; Beyzarov, Elena; Zhang, Xiaoxi; Ferrier, Graham; Zhang, Xiaosong; Tabernero, Josep

Lenvatinib Plus Pembrolizumab and Chemotherapy Versus Chemotherapy in Advanced Metastatic Gastroesophageal Adenocarcinoma: The Phase III, Randomized LEAP-015 Study

乐伐替尼联合帕博利珠单抗和化疗对比单纯化疗治疗晚期转移性胃食管腺癌:III期随机LEAP-015研究

Shitara, Kohei; Lorenzen, Sylvie; Li, Jin; Bai, Yuxian; Fernández, Manuel González; Aguilar, Mynor; Shoji, Hirokazu; Reyes-Cosmelli, Felipe; Peña, Yovany Rodriguez; Corrales, Luis; Wyrwicz, Lucjan; Eyzaguirre, Daniel Acosta; Pan, Yueyin; Ryu, Min-Hee; Cohen, Deirdre J; Wainberg, Zev A; Ku, Geoffrey; Tabernero, Josep; Van Cutsem, Eric; Qin, Shu-Kui; Oh, Do-Youn; Xu, Jianming; Liang, Li Wen; Bordia, Sonal; Bhagia, Pooja; Rha, Sun Young

Characteristics of Patients and Prognostic Factors Across Treatment Lines in Metastatic Colorectal Cancer: An Analysis From the Aide et Recherche en Cancérologie Digestive Database

转移性结直肠癌不同治疗线患者特征及预后因素:来自 Aide et Recherche en Cancérologie Digestive 数据库的分析

Bachet, Jean-Baptiste; de Gramont, Aimery; Raeisi, Morteza; Rakez, Manel; Goldberg, Richard M; Tebbutt, Niall C; Van Cutsem, Eric; Haller, Daniel G; Hecht, J Randolph; Mayer, Robert J; Lichtman, Stuart M; Benson, Al B; Sobrero, Alberto F; Tabernero, Josep; Adams, Richard; Zalcberg, John R; Grothey, Axel; Yoshino, Takayuki; André, Thierry; Shi, Qian; Chibaudel, Benoist

NOTCH1 Mutation and Survival Analysis of Tislelizumab in Advanced or Metastatic Esophageal Squamous Cell Carcinoma: A Biomarker Analysis From the Randomized, Phase III, RATIONALE-302 Trial.

NOTCH1 突变与替利珠单抗治疗晚期或转移性食管鳞状细胞癌的生存分析:来自随机 III 期 RATIONALE-302 试验的生物标志物分析

Lu Zhihao, Du Wenting, Jiao Xi, Wang Yanni, Shi Jingwen, Shi Yang, Shu Yongqian, Niu Zuoxing, Hara Hiroki, Wu Jun, Hsu Chih-Hung, Van Cutsem Eric, Brock Malcolm V, Zhang Zhang, Ding Ningning, Zhang Yun, Shen Zhirong, Shen Lin

Single-cell RNA sequencing-derived signatures define response patterns to atezolizumab + bevacizumab in advanced hepatocellular carcinoma

单细胞RNA测序衍生的特征谱定义了晚期肝细胞癌对阿特珠单抗+贝伐珠单抗的反应模式

Cappuyns, Sarah; Piqué-Gili, Marta; Esteban-Fabró, Roger; Philips, Gino; Balaseviciute, Ugne; Pinyol, Roser; Gris-Oliver, Albert; Vandecaveye, Vincent; Abril-Fornaguera, Jordi; Montironi, Carla; Bassaganyas, Laia; Peix, Judit; Zeitlhoefler, Marcus; Mesropian, Agavni; Huguet-Pradell, Júlia; Haber, Philipp K; Figueiredo, Igor; Ioannou, Giorgio; Gonzalez-Kozlova, Edgar; D'Alessio, Antonio; Mohr, Raphael; Meyer, Tim; Lachenmayer, Anja; Marquardt, Jens U; Reeves, Helen L; Edeline, Julien; Finkelmeier, Fabian; Trojan, Jörg; Galle, Peter R; Foerster, Friedrich; Mínguez, Beatriz; Montal, Robert; Gnjatic, Sacha; Pinato, David J; Heikenwalder, Mathias; Verslype, Chris; Van Cutsem, Eric; Lambrechts, Diether; Villanueva, Augusto; Dekervel, Jeroen; Llovet, Josep M

Inflammation and mutational burden differentially associated with nivolumab or ipilimumab combination efficacy in colorectal cancer

炎症和突变负荷与纳武利尤单抗或伊匹木单抗联合治疗结直肠癌的疗效存在差异性关联

Lei, Ming; Overman, Michael J; Yao, Jin; André, Thierry; Lonardi, Sara; Lenz, Heinz-Josef; Aglietta, Massimo; Gelsomino, Fabio; McDermott, Ray; Wong, Ka Yeung Mark; Morse, Michael A; Van Cutsem, Eric; Hendlisz, Alain; Cardin, Dana B; Neyns, Bart; Hill, Andrew; Krishnamurthy, Anuradha; Chen, Franklin; Kochuparambil, Samith; Jenq, Robert R; Abdullaev, Sandzhar; He, Beilei; Novosiadly, Ruslan; Kopetz, Scott

CA19-9 as a Dynamic Biomarker for Continuous Monitoring of Therapeutic Efficacy in Pancreatic Adenocarcinoma

CA19-9 作为动态生物标志物用于胰腺腺癌治疗效果的连续监测

Brancato, Luigi; Osok, Damar; Van den Bossche, Laurent; Van Cutsem, Eric; Bates, Susan E; Van den Bossche, Johan; Bogers, Johannes

Associations between early tumor shrinkage/depth of response and survival from the ARCAD database

ARCAD数据库中早期肿瘤缩小/反应深度与生存率之间的关联

Bando, Hideaki; Takeda, Yuriko; Misumi, Toshihiro; Nishikawa, Tomomi; Wakabayashi, Masashi; Yamazaki, Kentaro; Oki, Eiji; Douillard, Jean-Yves; Punt, Cornelis J A; Koopman, Miriam; Van Cutsem, Eric; Bokemeyer, Carsten; Venook, Alan P; Lenz, Heinz-Josef; Maehara, Yoshihiko; Andre, Thierry; Shi, Qian; de Gramont, Aimery; Yoshino, Takayuki